Membrane-select regulation of cardiac Na v channel isoforms

Heart Rhythm

Volumn 8, Issue 12, 2011, Pages 1931-1932

  Mohler, Peter J ^a,b   Hund, Thomas J ^a,c  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c Ohio State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; ANKYRIN B; ANKYRIN G; SODIUM CHANNEL NAV1.1; SODIUM CHANNEL NAV1.3; SODIUM CHANNEL NAV1.5; SODIUM CHANNEL NAV1.6; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL;

ATAXIA; BRUGADA SYNDROME; EPILEPSY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; LONG QT SYNDROME; MEMBRANE DEPOLARIZATION; MYOTONIA; NOTE; PRIORITY JOURNAL; SINUS NODE DISEASE; SODIUM CHANNELOPATHY;

EID: 82455209587     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2011.08.002     Document Type: Editorial

References (25)

1. Nattel S, Maguy A, Le Bouter S, Yeh YH. Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev 2007;87:425-456.
2. Wilde AA, Brugada R. Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac sodium channel. Circ Res 2011;108:884-897.
3. Waxman SG. Channel, neuronal and clinical function in sodium channelopathies: from genotype to phenotype. Nat Neurosci 2007;10:405-409.
4. Lehnart SE, Ackerman MJ, Benson DW, Jr., et al. Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function. Circulation 2007;116:2325-2345.
5. Mohler PJ, Rivolta I, Napolitano C, et al. Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes. Proc Natl Acad Sci USA 2004;101:17533-17538.
6. Medeiros-Domingo A, Kaku T, Tester DJ, et al. SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome. Circulation 2007;116:134-142.
7. Vatta M, Ackerman MJ, Ye B, et al. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation 2006;114: 2104-2112.
8. London B, Michalec M, Mehdi H, et al. Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na- current and causes inherited arrhythmias. Circulation 2007;116:2260-2268.
9. Lin X, Liu N, Lu J, et al. Subcellular heterogeneity of sodium current properties in adult cardiac ventricular myocytes. Heart Rhythm 2011;8:1923-1930.
10. Fozzard HA, Hanck DA. Structure and function of voltage-dependent sodium channels: comparison of brain II and cardiac isoforms. Physiol Rev 1996;76: 887-926.
11. Maier SK, Westenbroek R.E., McCormick KA, Curtis R, Scheuer T, Catterall WA. Distinct subcellular localization of different sodium channel alpha and beta subunits in single ventricular myocytes from mouse heart. Circulation 2004;109: 1421-1427.
12. Maier SK, Westenbroek R.E., Schenkman KA, Feigl EO, Scheuer T, Catterall WA. An unexpected role for brain-type sodium channels in coupling of cell surface depolarization to contraction in the heart. Proc Natl Acad Sci USA 2002;99:4073-4078.
13. Abriel H, Kass RS. Regulation of the voltage-gated cardiac sodium channel Nav1.5 by interacting proteins. Trends Cardiovasc Med 2005;15:35-40.
14. Bhasin N, Cunha SR, Mduannayake M, Gigena MS, Rogers TB, Mohler PJ. Molecular basis for PP2A regulatory subunit B56 alpha targeting in cardiomyocytes. Am J Physiol Heart Circ Physiol 2007;293:H109-119.
15. Hashemi SM, Hund TJ, Mohler PJ. Cardiac ankyrins in health and disease. J Mol Cell Cardiol 2009;47:203-209.
16. Lowe JS, Palygin O, Bhasin N, et al. Voltage-gated Nav channel targeting in the heart requires an ankyrin-G dependent cellular pathway. J Cell Biol 2008;180: 173-186.
17. Hund TJ, Koval OM, Li J, et al. A betaIV spectrin/CaMKII signaling complex is essential for membrane excitability in mice. J Clin Invest 2010;120:3508-3519.
18. Hund TJ, Wright PJ, Dun W, Snyder JS, Boyden PA, Mohler PJ. Regulation of the ankyrin-B-based targeting pathway following myocardial infarction. Cardiovasc Res 2009;81:742-749.
19. Le Scouarnec S, Bhasin N, Vieyres C, et al. Dysfunction in ankyrin-B-dependent ion channel and transporter targeting causes human sinus node disease. Proc Natl Acad Sci USA 2008;105:15617-15622.
20. Mohler PJ, Schott JJ, Gramolini AO, et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 2003;421:634-639.
21. Cunha SR, Hund TJ, Hashemi S, et al. Defects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillation. Circulation 2011;124: 1212-1222.
22. Sato PY, Coombs W, Lin X, et al. Interactions between ankyrin-g, plakophilin-2, and connexin43 at the cardiac intercalated disc. Circ Res 2011;109:193-201.
23. Petitprez S, Zmoos AF, Ogrodnik J, et al. SAP97 and dystrophin macromolecular complexes determine two pools of cardiac sodium channels Nav1.5 in cardiomyocytes. Circ Res 2011;108:294-304.
24. Kucera JP, Rohr S, Rudy Y. Localization of sodium channels in intercalated disks modulates cardiac conduction. Circ Res 2002;91:1176-1182.
25. Mori Y, Fishman GI, Peskin CS. Ephaptic conduction in a cardiac strand model with 3D electrodiffusion. Proc Natl Acad Sci USA 2008;105:6463-6468.